| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |